Benzocaine Repeat-Dosing, Three-Arm Trials Recommended By FDA’s Ganley
This article was originally published in The Tan Sheet
Executive Summary
A three-arm benzocaine study is necessary to determine whether the existing 20% and 10% strengths are equally effective for toothache pain relief, according to FDA Division of OTC Drug Products Director Charles Ganley, MD
You may also be interested in...
Benzocaine Monograph For Toothache Requires Further Study – FDA
FDA says benzocaine-containing oral analgesic manufacturers will have to conduct a larger clinical trial to support a Category I (safe and effective) classification for the treatment of toothaches
Benzocaine Monograph For Toothache Requires Further Study – FDA
FDA says benzocaine-containing oral analgesic manufacturers will have to conduct a larger clinical trial to support a Category I (safe and effective) classification for the treatment of toothaches
Benzocaine Monograph For Toothache Requires Further Study – FDA
FDA says benzocaine-containing oral analgesic manufacturers will have to conduct a larger clinical trial to support a Category I (safe and effective) classification for the treatment of toothaches